Nutrilite Memory Builder on the Improvement of Cognitive Function

Last updated: April 26, 2023
Sponsor: Amway (China) R&D Center
Overall Status: Active - Recruiting

Phase

N/A

Condition

Brain Function

Treatment

N/A

Clinical Study ID

NCT05591885
IS20220006RD
  • Ages 40-75
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Its a randomized controlled trial, to evaluate the effect of NUTRILITE Memory Builder on the improvement of cognitive function in middle-aged and elderly people.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Males or females, 40-75 years old (with age groups of 40-60 years and 61-75 years asclose as possible to a 1:1 ratio);
  • Healthy subjects with no underlying diseases and no drug treatment at the time ofscreening;
  • Meet the requirements of MMSE scores of 24-29;
  • Be willing to comply with all study requirements and procedures;
  • Agree to sign the informed consent form.

Exclusion

Exclusion Criteria:

  • Participated in similar clinical trials in the last 6 months;
  • Have mental illness or disorders of consciousness and behavior;
  • Have severe chronic diseases and are currently under treatment with drugs;
  • Have taken drugs that can affect cognitive function (such as first-generationantihistamines, benzodiazepines, sedatives, opiates, stabilizers, antidepressants,cholinergic drugs, anticholinergic drugs, prescription anti-inflammatory drugs) andany other regularly influential agents.
  • Had flu/virus symptoms within 3 months before screening;
  • Received within 3 months before screening or currently receiving medical ornutritional treatments, including protein supplementation or substances that provideexercise capacity;
  • Had weight gain or weight loss of more than 5kg within 3 months before screening;
  • Have a history of hospitalization within 3 months before screening;
  • Have any of the following medical history or have been clinically diagnosed with anyof the following diseases: obvious gastrointestinal disorders; liver, kidney,endocrine, blood, respiratory and cardiovascular diseases. These may affect theassessment of product efficacies.
  • Have high daily alcohol consumption, i.e. more than 14 bottles of beer (350 ml/bottle)or wine (180 ml/bottle) per week;
  • The PI believes that the subjects cannot fully cooperate with the trial arrangement.

Study Design

Total Participants: 100
Study Start date:
October 24, 2022
Estimated Completion Date:
May 31, 2023

Study Description

The study center will recruit 100 male or female subjects aged 40-75 years as needed. Enrolled subjects will be divided into 2 groups, with 50 subjects in each group.

Study subjects will be administrated with either the Amway product or a placebo for three months (12 weeks). At least 42 subjects in each group (84 in total) are required to complete the study.

Connect with a study center

  • Kangrong Clinic

    Jinhua, Zhejiang 321041
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.